Akshay Bansarilal Arora, promoter of blue jet healthcare , has declared that no encumbrance was created on the equity holdings of himself and associated persons acting in concert (PACs) during the financial year ended March 31, 2026. The declaration confirms that the promoter group’s stake of 79.81% remains free of any charges or pledges, ensuring stability in the company’s ownership structure for investors. This filing is a mandatory annual compliance under SEBI regulations, providing transparency regarding the security status of promoter-held shares.

The disclosure was submitted pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Akshay Bansarilal Arora signed the declaration on April 7, 2026, in Navi Mumbai, affirming that the information provided is true and correct. The regulation requires substantial shareholders to annually declare whether any encumbrance has been created on their shareholdings directly or indirectly.

Shareholding Structure of Promoters and PACs

The declaration covers the equity holdings of Akshay Bansarilal Arora and five other entities classified as promoters or part of the promoter group. The table below details the number of shares held and the corresponding percentage of voting capital for each entity as disclosed in the filing.

Analysis of Promoter Holdings

The data reveals a highly concentrated ownership structure, with Akshay Bansarilal Arora holding the majority stake at 62.80%. His son, Shiven Akshay Arora, and daughter, Archana Akshay Arora, hold significant portions at 10.96% and 6.05% respectively, indicating family-controlled governance. The remaining three entities—Alka Rakesh Bakshi, Amit Dhawan, and Anisha Juneja—are categorized as part of the promoter group but hold negligible stakes of only 10 shares each, contributing 0.00% to the total voting capital. The absence of any new encumbrances suggests that the promoters are not leveraging their shareholdings for external funding during this period, which is generally viewed as a positive signal for corporate governance and financial stability.

Blue Jet Healthcare Limited has been awarded the EcoVadis Silver Medal for its sustainability management practices, placing it in the top 15% of companies evaluated globally. The company achieved an EcoVadis Sustainability Score of 77 out of 100, reflecting its performance in Environment, Labor and Human Rights, Ethics, and Sustainable Procurement. This recognition underscores the company's commitment to embedding environmental, social, and governance (ESG) principles into its operations.

EcoVadis assessed the company across four key themes: environment, labor and human rights, ethics, and sustainable procurement. The Silver Medal designation indicates a 90th percentile ranking in sustainability performance. This achievement marks a progression from the EcoVadis Committed Badge the company previously earned.

Management Commentary

Mr. Shiven Akshay Arora, Managing Director, stated that the award marks a significant milestone in the company's sustainability journey. He noted that the recognition reflects meaningful progress in strengthening environmental, social, ethical, and governance practices across operations. He attributed the achievement to the collective efforts of employees, business partners, and stakeholders.

Sustainability Scorecard

Company Profile

Established in 1968, blue jet healthcare is a manufacturer of specialty chemicals and pharmaceutical intermediates serving global pharmaceutical companies. The company operates with a focus on quality, compliance, and governance-led growth.